Imagen de Portada

High‐dose amphetamines associated with increased risk of psychosis, mania

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	The Brown University Psychopharmacology Update
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Antidepressants for bipolar depression do not increase risk of mania
Publicado: (2024)

ED visit for psychedelic use confers increased risk of psychosis
Publicado: (2025)

Antipsychotic dose reduction/discontinuation in first‐episode psychosis carries short‐term risks
Publicado: (2026)

Psychedelics and psychosis: Quantifying the risk
por: Lawrence H. Price
Publicado: (2025)

Pimavanserin reduced risk of relapse to psychosis in Parkinson's dementia
Publicado: (2024)

No protective effect of omega‐3s for youths at risk of psychosis
Publicado: (2025)

Benzodiazepine use not associated with increased risk of dementia
Publicado: (2024)

Some anti‐psychotics associated with increased risk of pneumonia
Publicado: (2024)

Meta‐analysis suggests risk of psychosis from stimulant treatment for ADHD
Publicado: (2025)

Postpartum hormonal contraceptives increase risk of depression
Publicado: (2025)

Review finds VMAT‐2 inhibitors promising for treatment of psychosis
Publicado: (2024)

Use of SSRIs with anticoagulants can increase risk of bleeding
Publicado: (2024)

Low dose of esketamine after childbirth helps mothers at risk of depression
Publicado: (2024)

Combination of SSRI and methylphenidate does not increase adverse event risk
Publicado: (2024)

GLP‐1 receptor agonists not associated with increased suicidality
Publicado: (2024)

Discontinuation of benzodiazepines after long‐term use increases mortality risk
Publicado: (2024)

Meta‐analysis finds no increase in suicide risk from use of isotretinoin
Publicado: (2024)

GLP‐1s did not increase suicide risk in patients with type 2 diabetes
Publicado: (2025)

Analysis suggests risk of suicidal ideation associated with semaglutide
Publicado: (2024)

Study finds semaglutide not associated with higher risk of suicidality
Publicado: (2024)

Higher‐dose buprenorphine linked to reduced health care utilization
Publicado: (2024)

Use of ADHD medications increased sharply during pandemic
Publicado: (2024)

Second‐line strategies more effective than dose optimization in depression treatment
Publicado: (2025)

Single‐dose psilocybin with CBT more effective than nicotine patch for smoking cessation
Publicado: (2026)

Loneliness in early adolescence associated with increased risk for mental disorders
por: Alison Knopf
Publicado: (2026)

Antimicrobial exposure and risk of depression
por: Y. W. Francis Lam
Publicado: (2025)

Clozapine‐associated pneumonia
por: Y. W. Francis Lam
Publicado: (2025)

LAI added to clozapine reduces risk of hospitalization
Publicado: (2024)

Cannabis‐related hospitalization linked to risk of dementia
Publicado: (2025)

Antipsychotic‐associated breast cancer
por: Y. W. Francis Lam
Publicado: (2024)

Patients with COPD show risk of worsening from gabapentinoids
Publicado: (2024)

Higher autism risk with valproate than topiramate, lamotrigine
Publicado: (2024)

Antipsychotic classes differ in risk of cardio‐cerebrovascular mortality
Publicado: (2024)

Antipsychotics linked to reduced suicide risk in patients with schizophrenia
Publicado: (2025)

First‐line antidepressants decrease fall risk in elderly with depression
Publicado: (2024)

Heatwaves exacerbate risk of illnesses in patients with mental health conditions
Publicado: (2025)

Small differences in weight gain risk among commonly used antidepressants
Publicado: (2024)

Anti‐psychotic use in dementia patients linked to risk of numerous illnesses
Publicado: (2024)

Review of GLP‐1 trials finds low incidence of suicide risk
Publicado: (2025)

Paternal exposure to valproate linked to higher risk of neurodevelopmental disorders in offspring
Publicado: (2026)